Pin1 plays a key role in the response to treatment and clinical outcome in triple negative breast cancer

by Catherine Knowlson, Paula Haddock, Victoria Bingham, Stephen McQuaid, Paul B. Mullan, Niamh E. Buckley
Published 2020-03-01

NUP98 – a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer

by Paul B. Mullan, Victoria Bingham, Paula Haddock, Gareth W. Irwin, Elaine Kay, Stephen McQuaid, Niamh E. Buckley
Published 2019-04-01

Glucocorticoid Receptor Expression Predicts Good Outcome in response to Taxane-Free, Anthracycline-Based Therapy in Triple Negative Breast Cancer

by Ahmed Elkashif, Victoria Bingham, Paula Haddock, Matthew P. Humphries, Stephen McQuaid, Paul B. Mullan, Helen O. McCarthy, Niamh E. Buckley
Published 2020-01-01